Dimitry Sa Nuyten Arcus Biosciences, Inc. (RCUS) insider trading activity

Dimitry Sa Nuyten is Chief Medical Officer of Arcus Biosciences, Inc.. Currently has a direct ownership of 87,518 shares of RCUS, which is worth approximately $1.36 Million. The most recent transaction as insider was on Dec 15, 2024, when has been sold 7,856 shares (Common Stock) at a price of $16.08 per share, resulting in proceeds of $126,324. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.5K

7.81% 3M change

22.93% 12M change

Total Value Held $1.36 Million

Dimitry SA Nuyten Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2024	SELL Payment of exercise price or tax liability	$126,324 $16.08 p/Share	7,856 Reduced 8.24%	87,518 Common Stock
Sep 15 2024	SELL Payment of exercise price or tax liability	$96,660 $17.95 p/Share	5,385 Reduced 5.37%	94,933 Common Stock
Jan 23 2024	BUY Grant, award, or other acquisition	-	28,000 Added 22.01%	99,195 Common Stock
Dec 19 2023	SELL Sale (or disposition) back to the issuer	$27,858 $18.09 p/Share	1,540 Reduced 2.12%	71,195 Common Stock
Dec 18 2023	SELL Sale (or disposition) back to the issuer	$26,734 $17.74 p/Share	1,507 Reduced 2.03%	72,735 Common Stock
Sep 18 2023	SELL Sale (or disposition) back to the issuer	$75,643 $20.4 p/Share	3,708 Reduced 4.8%	73,591 Common Stock
Jan 23 2023	BUY Grant, award, or other acquisition	-	34,000 Added 30.77%	76,500 Common Stock
Aug 23 2022	BUY Grant, award, or other acquisition	-	42,500 Added 50.0%	42,500 Common Stock

DSN

Dimitry Sa Nuyten

Chief Medical Officer

Hayward, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCUS shares.

Notify only if

Value

Insider Trading

Get notified when an Arcus Biosciences, Inc. insider buys or sells RCUS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcus Biosciences, Inc.

Track Activities on RCUS

Account